Increased antibody response after SARS-CoV-2 mRNA-based vaccination in rituximab-treated patients with previous COVID-19 infection.

Jerome AvouacRoba GhossanOmar Al TabaaAlice CombierAlexia SteelandtMarion ThomasOlivier FogelAlice Andrée MariaggiJean-François MeritetFlore RozenbergAnna MoltóCorinne Miceli-RichardYannick Allanore

Published in: Rheumatology (Oxford, England) (2022)

Keyphrases

sars cov
diffuse large b cell lymphoma
respiratory syndrome coronavirus
hodgkin lymphoma
binding protein
chronic lymphocytic leukemia
newly diagnosed